Publications
Found 2 results
Filters: Author is Y.Y. Wan [Clear All Filters]
“Association between the c.1564A>T genetic polymorphism of the MDR1 gene and hepatocellular carcinoma in Chinese population”, vol. 13, pp. 6820-6826, 2014.
, “Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population”, vol. 11, pp. 548-555, 2012.
, Bange J, Prechtl D, Cheburkin Y, Specht K, et al. (2002). Cancer progression and tumor cell motility are associated with the FGFR4 Arg388 allele. Cancer Res. 62: 840-847.
PMid:11830541
Buch S, Schafmayer C, Volzke H, Becker C, et al. (2007). A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat. Genet. 39: 995-999.
http://dx.doi.org/10.1038/ng2101
PMid:17632509
Buch S, Schafmayer C, Volzke H, Seeger M, et al. (2010). Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology 139: 1942-1951.
http://dx.doi.org/10.1053/j.gastro.2010.09.003
PMid:20837016
Chan T, Yaghoubian A, Rosing D, Lee E, et al. (2008). Total bilirubin is a useful predictor of persisting common bile duct stone in gallstone pancreatitis. Am. Surg. 74: 977-980.
PMid:18942626
Choi M, Moschetta A, Bookout AL, Peng L, et al. (2006). Identification of a hormonal basis for gallbladder filling. Nat. Med. 12: 1253-1255.
http://dx.doi.org/10.1038/nm1501
PMid:17072310
Donovan JM (1999). Physical and metabolic factors in gallstone pathogenesis. Gastroenterol. Clin. North Am. 28: 75-97.
http://dx.doi.org/10.1016/S0889-8553(05)70044-3
Falvella FS, Frullanti E, Galvan A, Spinola M, et al. (2009). FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. Int. J. Cancer 124: 2880- 2885.
http://dx.doi.org/10.1002/ijc.24302
PMid:19296538
Hylemon PB, Zhou H, Pandak WM, Ren S, et al. (2009). Bile acids as regulatory molecules. J. Lipid Res. 50: 1509-1520.
http://dx.doi.org/10.1194/jlr.R900007-JLR200
PMid:19346331 PMCid:2724047
Jiang ZY, Han TQ, Suo GJ, Feng DX, et al. (2004). Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease. World J. Gastroenterol. 10: 1508-1512.
PMid:15133863
Johnston DE and Kaplan MM (1993). Pathogenesis and treatment of gallstones. N. Engl. J. Med. 328: 412-421.
http://dx.doi.org/10.1056/NEJM199302113280608
PMid:8421460
Jones S (2008). Mini-review: endocrine actions of fibroblast growth factor 19. Mol. Pharm. 5: 42-48.
http://dx.doi.org/10.1021/mp700105z
PMid:18179175
Lammert F and Sauerbruch T (2005). Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 423-433.
http://dx.doi.org/10.1038/ncpgasthep0257
Miyasaka K, Takata Y and Funakoshi A (2002). Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism. J. Gastroenterol. 37 (Suppl 14): 102-106.
PMid:12572876
Russell DW and Setchell KD (1992). Bile acid biosynthesis. Biochemistry 31: 4737-4749.
http://dx.doi.org/10.1021/bi00135a001
PMid:1591235
Srivastava A, Pandey SN, Choudhuri G and Mittal B (2008). Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer. Mol. Genet. Metab. 94: 83-89.
http://dx.doi.org/10.1016/j.ymgme.2007.11.014
PMid:18178499
Strasberg SM (1997). Cholelithiasis and acute cholecystitis. Baillieres Clin. Gastroenterol. 11: 643-661.
http://dx.doi.org/10.1016/S0950-3528(97)90014-2
Strasberg SM and Clavien PA (1992). Cholecystolithiasis: lithotherapy for the 1990s. Hepatology 16: 820-839.
http://dx.doi.org/10.1002/hep.1840160332
PMid:1387104
Wang J, Stockton DW and Ittmann M (2004). The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression. Clin. Cancer Res. 10: 6169-6178.
http://dx.doi.org/10.1158/1078-0432.CCR-04-0408
PMid:15448004
Wang J, Yu W, Cai Y, Ren C, et al. (2008). Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 10: 847-856.
PMid:18670643 PMCid:2481572
Ye Y, Shi Y, Zhou Y, Du C, et al. (2010). The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression. Ann. Surg. Oncol. 17: 3354-3361.
http://dx.doi.org/10.1245/s10434-010-1323-6
PMid:20844967
Yu C, Wang F, Kan M, Jin C, et al. (2000). Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275: 15482-15489.
http://dx.doi.org/10.1074/jbc.275.20.15482
PMid:10809780
Yu C, Wang F, Jin C, Huang X, et al. (2005). Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J. Biol. Chem. 280: 17707-17714.
http://dx.doi.org/10.1074/jbc.M411771200
PMid:15750181